SK
Sky Century Investment, Inc.
SKYI · OTC
$0.10 +0.00% (+$0.00)
1M -25.37%
Market Cap $223.5K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.13
30.0% upside
Current Price
$0.1
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SKYI is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
82 /100
Cheap P/S 1.77x
EV/EBITDA N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 19.07%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 49.48%
Op. margin 49.48%
FCF margin 102.42%
Quality
75 /100
Excellent ROA 48.57%
Asset turnover 0.98x
ROIC 77.64%
Debt
0 /100
High Current ratio 0.04x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
33 /100
Unstable Rev. volatility 103.58%
EPS volatility 12.83%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SKYI
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Nataliia Petranetska
Employees
1
Headquarters
Las Vegas